Company Overview of Qiagen Marseille Société Anonyme
QIAGEN Marseille S.A., a molecular diagnosis company, develops and markets diagnostic tests in the field of oncology worldwide. The company offers diagnostic kits and biomarkers. Its products are used in the diagnosis, prognosis, and monitoring of patients with leukemia. The company was formerly known as IPSOGEN S.A. and changed its name to QIAGEN Marseille S.A. in January 2013. The company was founded in 1999 and is headquartered in Marseille, France. QIAGEN Marseille S.A. is a subsidiary of HalioDx.
Luminy Biotech Entreprises
163 avenue de Luminy
Founded in 1999
33 4 91 29 30 90
33 4 91 29 30 99
Key Executives for Qiagen Marseille Société Anonyme
Qiagen Marseille Société Anonyme Key Developments
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Qiagen Marseille Société Anonyme, please visit www.qiagenmarseille.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.